Immunosuppressive therapy and COVID‐19 infection in patients with NMOSD
Abstract Introduction To evaluate whether treated with immunosuppressants in neuromyelitis optica spectrum disorder (NMOSD) shows an effect on the severity and outcomes of COVID‐19 Omicron variant. Methods This is a substudy of a single‐center clinical trial involving human umbilical cord mesenchyma...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.1128 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|